Overview

A Study of Vinflunine in Patients With Gastric Cancer

Status:
Terminated
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if vinflunine can shrink or slow the growth of cancer in patients with advanced or metastatic stomach cancer who have progressed on a prior treatment with a fluoropyrimidine or taxane-containing chemotherapy regimen. The safety of this treatment will also be studied.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Vinblastine